login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
PROCEPT BIOROBOTICS CORP (PRCT) Stock News
USA
- NASDAQ:PRCT -
US74276L1052
-
Common Stock
36.66
USD
-0.36 (-0.97%)
Last: 9/26/2025, 8:24:00 PM
36.65
USD
-0.01 (-0.03%)
After Hours:
9/26/2025, 8:24:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PRCT Latest News, Press Relases and Analysis
All
Press Releases
25 days ago - By: Benzinga
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts
a month ago - By: Zacks Investment Research
- Mentions:
ISRG
GMED
SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?
a month ago - By: Yahoo Finance
- Mentions:
WFC
PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift
2 months ago - By: Yahoo Finance
Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)
2 months ago - By: Benzinga
- Mentions:
OEC
VTLE
DIN
INSE
...
Earnings Scheduled For August 6, 2025
2 months ago - By: The Motley Fool
Procept (PRCT) Q2 Revenue Jumps 48%
2 months ago - By: Zacks Investment Research
- Mentions:
NPCE
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
2 months ago - By: The Motley Fool
PROCEPT BioRobotics (PRCT) Earnings Transcript
2 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
2 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
2 months ago - By: Zacks Investment Research
- Mentions:
AXGN
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
2 months ago - By: Zacks Investment Research
- Mentions:
SIBN
Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates
2 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
2 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
2 months ago - By: PROCEPT BioRobotics
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
2 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
2 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
2 months ago - By: PROCEPT BioRobotics
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
2 months ago - By: PROCEPT BioRobotics
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
5 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
5 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
5 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
5 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
5 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
5 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
6 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
6 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
6 months ago - By: Yahoo Finance
- Mentions:
BRKA
BRKB
MSFT
MELI
...
Warren Buffett Has Seen His Share of Market Downturns. His Message to Investors: Keep Your Cool.
6 months ago - By: Yahoo Finance
- Mentions:
MS
C
TSLA
PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires
6 months ago - By: PROCEPT BioRobotics
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
6 months ago - By: PROCEPT BioRobotics
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
7 months ago - By: PROCEPT BioRobotics
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
Please enable JavaScript to continue using this application.